Tag Archives: atrial

DOACs now recommended over warfarin to prevent blood clots in people with atrial fibrillation

For decades, warfarin (Coumadin) was the standard anticoagulant medication used to prevent blood clots, which can lead to stroke, in people with atrial fibrillation (afib). Direct oral anticoagulants (DOACs), sometimes called novel oral anticoagulants (NOACs), are a new type of anticoagulant medication that came on the market in 2010. In 2019, the American Heart Association/American… Read More »